Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins

scientific article published on 8 June 2016

Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/21541248.2016.1189990
P932PMC publication ID5331900
P698PubMed publication ID27275775

P50authorFrank KirchhoffQ15451512
Dominik HotterQ61157848
P2093author name stringDaniel Sauter
P2860cites workInhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160Q22251286
Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensingQ24318920
Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infectionQ24336824
MX2 is an interferon-induced inhibitor of HIV-1 infectionQ24338311
Golgi targeting of human guanylate-binding protein-1 requires nucleotide binding, isoprenylation, and an IFN-gamma-inducible cofactorQ24529563
Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virionsQ39520401
MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.Q40927400
SnapShot: antiviral restriction factorsQ41190470
Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion productionQ41624661
Dynamins are forever: MxB inhibits HIV-1.Q42261347
The interferon-inducible MxB protein inhibits HIV-1 infection.Q42267969
A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG.Q42613411
Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B proteinQ42991703
High frequency of defective vpu compared with tat and rev genes in brain from patients with HIV type 1-associated dementiaQ48079997
Role of CD4 and CCR5 Levels in the Susceptibility of Primary Macrophages to Infection by CCR5-Dependent HIV Type 1 IsolatesQ59661561
In silico genomic analysis of the human and murine guanylate-binding protein (GBP) gene clustersQ83321178
Donor variation in in vitro HIV-1 susceptibility of monocyte-derived macrophagesQ84079241
The restriction factors of human immunodeficiency virusQ24605108
Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twinsQ27469707
HIV-1 accessory proteins--ensuring viral survival in a hostile environmentQ29619538
A Naturally Occurring rev1-vpu Fusion Gene Does Not Confer a Fitness Advantage to HIV-1.Q30381208
Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentivirusesQ30391530
Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virusQ33177702
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individualsQ33535874
Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Q33640055
The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency virusesQ33826504
A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivityQ34005516
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infectionsQ34042642
Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cellsQ34291056
The interferon-induced 67-kDa guanylate-binding protein (hGBP1) is a GTPase that converts GTP to GMP.Q34291528
Phenotypic properties of transmitted founder HIV-1Q34336058
HIV-1 and interferons: who's interfering with whom?Q34473801
Unique features of different members of the human guanylate-binding protein family.Q34607986
APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate hostQ35008780
HIV-1 replication and the cellular eukaryotic translation apparatusQ35014929
HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporationQ35113720
Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteinsQ35549043
Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analysesQ35616862
Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAsQ35857341
HIV Restriction Factors and Mechanisms of EvasionQ35902681
Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated CytotoxicityQ36086204
IFN-inducible GTPases in host cell defenseQ36374867
Guanylate-binding protein 1 participates in cellular antiviral response to dengue virusQ36462912
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomesQ36796806
Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesisQ37995691
Rules of engagement: molecular insights from host-virus arms racesQ38059240
Cellular Antiviral Factors that Target Particle Infectivity of HIV-1Q38671133
MxB Is Not Responsible for the Blocking of HIV-1 Infection Observed in Alpha Interferon-Treated CellsQ38807646
90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.Q39071268
Guanylate Binding Protein (GBP) 5 Is an Interferon-Inducible Inhibitor of HIV-1 InfectivityQ39147587
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectinfectivityQ1662346
virionQ1757347
P304page(s)31-37
P577publication date2016-06-08
P1433published inSmall GTPases (journal)Q15709529
P1476titleGuanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins
P478volume8

Reverse relations

cites work (P2860)
Q55178733Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma.
Q89786983Effect of polymorphisms in porcine guanylate-binding proteins on host resistance to PRRSV infection in experimentally challenged pigs
Q92703239Interplay between Intrinsic and Innate Immunity during HIV Infection

Search more.